We have written before on the potential value of radioimmunotherapy (RIT) drugs such as Bexxar and Zevalin to CLL patients. In fact, we are monitoring with interest an important trial at the Hutchinson Cancer Center (Seattle) using Bexxar for MRD clearance in CLL patients. Here are links to our previous articles, for your quick reference:
Radioimmunotherapy is Underappreciated
Reimbursement cuts may sink RIT
Bexxar trial for CLL
With recent rulings by Medicare, we are in imminent danger of losing access to both of these drugs. Our sister organization www.lymphomation.org and its founder Karl Schwartz have been very active in trying to mobilize patient support for these two important drugs, and today is the day to make a couple of phone calls to your government representatives on this subject. I strongly urge you to support this initiative, and add your voice to the other patients trying to keep these therapy options for all of us. Please call Senator Max Baucus, as well as the senator from your state. The contact information is given below for your convenience. What should you say to these senators? Something along these lines, with as much gusto as you can muster:
“I am a cancer patient/caregiver and I'm calling about the CMS RULING that will cut reimbursement and therefore DENY ACCESS to potentially life saving radioimmunotherapy drugs Bexxar and Zevalin ... Please do what you can to fix this ruling before the end of the year. ....”
Senator Max Baucus (Montana) *
511 Hart Senate Office Bldg.
Washington, D.C. 20510
(202) 224-2651
(202) 224-0515 (Fax)
webmail: http://baucus.senate.gov/contact/emailForm.cfm?subj=issue
Majority Members
John D. "Jay"Rockerfeller IV (D-WV)
Jocelyn Moore: 202-224-6472
Kent Conrad (D-ND)
Lindsey Henjum: 202-224-2043
Jeff Bingaman (D-NM)
Frederick Isasi: 202-224-5521
John F. Kerry (D-MA)
Chris Dawe: 202-224-2742
Blanche Lincoln (D-AR)
Ashley Ridlon: 202-224-4843
Ron Wyden (D-OR)
Nicole Tapay: 202-224-5244
Chuck Schumer (D-NY)
Meghan Taira: 202-224-6542
Debbie Stabenow (D-MI)
Oliver Kim: 202-224-4822
Maria Cantwell (D-WA)
Dale Chung: 202-224-3441
Ken Salazar (D-CO)
Piper Su: 202-224-5852
Minority Members
Orrin Hatch ( R-UT)
Pattie L. DeLoatche : 202-224-6306
Trent Lott (R-MS)
Emily Chandler: 202-224-6253
Olympia J. Snowe (R-ME)
Bill Pewen: 202-224-5344
Jon Kyl (R-AZ)
Jennifer romans: 202-224-4521
Gordon H. Smith (R-OR)
Lindsay Morris: 202-228-5862
Jim Bunning (R-KY)
Holly Santry: 202-224-4343
Mike Crapo (R-ID)
Katie Oppenheim: 202-224-6142
Pat Roberts (R-KS)
Jennifer Swenson: 202-224-4774
John Ensign (R-NV)
Andrew Shaw: 202-224-6244
Wednesday, November 28, 2007
CLL Drug Legislation
This is from Chaya Venkat of CLL Topics:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment